Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JXHB2101110	Tepotinib片	tepotinib hydrochloride	Tablet	Chemical Drugs(2.4)	Supplementary Application	2021-12-09		Merck Healthcare KGaA			view
JXHB2200137	Tepotinib片	tepotinib hydrochloride	Tablet	Chemical Drugs	Supplementary Application	2022-09-16		Merck Healthcare KGaA			view
JXHL1900156	Tepotinib片	tepotinib hydrochloride	Tablet	Chemical Drugs(1)	Import Drug Application	2019-07-10	Merck Healthcare KGaA	Merck Healthcare KGaA	In Review	2019-07-09	view
JXHL1900187	Tepotinib片	tepotinib hydrochloride	Tablet	Chemical Drugs(1)	Import Drug Application	2019-08-02	Merck KGaA	Merck KGaA	In Review	2019-08-01	view
JXHL1900186	Tepotinib片	tepotinib hydrochloride	Tablet	Chemical Drugs(1)	Import Drug Application	2019-08-02	Merck KGaA	Merck KGaA	In Review	2019-08-01	view
JYHB2000563	Tepotinib片	tepotinib hydrochloride	Tablet	Chemical Drugs(1)	Supplementary Application	2020-05-16	默克雪兰诺（北京）医药研发有限公司	Merck Serono (Beijing) Pharmaceutical R&D Co Ltd	In Review	2020-05-15	view
JXHB2100026	Tepotinib片	tepotinib hydrochloride	Tablet	Chemical Drugs	Supplementary Application	2021-03-03	默克雪兰诺（北京）医药研发有限公司	Merck Serono (Beijing) Pharmaceutical R&D Co Ltd	In Review	2021-03-02	view